Janssen collaborates on gene therapies for retinal disorders
Janssen enters collaboration with MeiraGTx for the development and commercialization of retinal disorder gene therapies.
Archives for February 5, 2019
GSK indicates oncology intent with €3.7bn Merck deal
GSK moves to rebuild its oncology pipeline by partnering with Merck KGaA on an immuno-oncology drug candidate.